Search for: "Martin Price" Results 781 - 800 of 1,881
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Nov 2015, 11:13 am by Old Fox
True story: When I took the SAT (at Martin Luther King Jr. high school on West 65th street), right before the administrator guy said, “Open your books,” a kid raced into the room and took the chair right in front of me. [read post]
13 Nov 2015, 6:35 am by Jim Sedor
Many say they find Washington rental prices too high. [read post]
13 Nov 2015, 5:09 am by FHH Law
That being the case, you may want to hold off on any seasonal celebrations until, say, Martin Luther King Day. [read post]
10 Nov 2015, 12:00 am by D Daniel Sokol
Martin Obradovits is Going to the Discounter: Consumer Search with Local Market Heterogeneities. [read post]
9 Nov 2015, 1:28 pm by Alyssa Rosen
Advocacy groups with expertise in financial analysis have been warning that fossil fuel company stock prices may be overvalued, as limiting climate change might require that much coal, oil and gas be left in the ground. [read post]
6 Nov 2015, 10:26 am by Patrick A. Malone
The Internet, for example, can’t seem to find sufficient opprobrium for Martin Shkreli, the hedge funder whose Turing Pharmaceuticals acquired rights to the drug Daraprim and then immediately jacked the price of the infection-fighting medication from $13.50 to $750 in one night. [read post]
2 Nov 2015, 4:28 pm by David Jensen
“The cost of disassembling, moving and rebuilding the furniture would be significant; based on prior experience, CIRM’s Finance Director, Chila Silva-Martin, estimates that this cost would be approximately two-thirds of the cost of obtaining new furniture. [read post]
1 Nov 2015, 4:58 pm by Sabrina I. Pacifici
Katz, Daniel Martin and Bommarito, Michael James and Soellinger, Tyler and Chen, James Ming, Law on the Market? [read post]
30 Oct 2015, 4:54 am by INFORRM
Owning newspapers had depressed News Corp’s stock price. [read post]
27 Oct 2015, 11:30 am by D Daniel Sokol
Antonio Robles Martin-Laborda, Universidad Carlos III de Madrid - Faculty of Social Sciences and Law examine Exploitative Prices in European Competition Law. [read post]
18 Oct 2015, 12:15 pm by Ron Friedmann
Legal Project Management, Pricing, and Profitability. [read post]
16 Oct 2015, 1:56 pm by Kevin S. Little
Responding to public criticism, its CEO, Martin Shkreli, agreed to lower the price of the medication, but never did so. [read post]
11 Oct 2015, 3:43 am
  The Court found that this had to be viewed in light of the fact that the number of survey respondents who were likely actually ever to have bought or even tasted CRISTAL champagne is tiny, since only 30,000 – 40,000 bottles are sold in the UK annually and the lowest price at which they are available is £175. [read post]
6 Oct 2015, 4:34 am by Quinta Jurecic
… Do you think there’s time to debate whether you say yes or no, to wonder whether some day the price isn’t going to be too high, whether afterwards you’re going to be able to call yourself a man again? [read post]
28 Sep 2015, 9:15 pm by Walter Olson
As you probably know if you follow the news, a man named Martin Shkreli in charge of a startup firm called Turing Pharmaceuticals bought the rights to a drug called pyrimethamine (brand name Daraprim), used in the treatment of AIDS and malaria, and announced that he was jacking up its price from $13.60 to $750. [read post]
28 Sep 2015, 10:32 am by Mark Tushnet
Amid all the hullabaloo about the price rise Martin Shkreli sought for the generic drug he acquired, I still haven't seen a good explanation for why he was able to (attempt to) do it. [read post]
27 Sep 2015, 6:21 pm by Kevin LaCroix
The news has already led to the resignation of its embattled CEO, Martin Winterkorn. [read post]
24 Sep 2015, 8:43 am by Steve Brachmann
Shortly after acquiring Daraprim, Turing CEO Martin Shkreli raised its price by more than 5,000 percent, from $13.50 per pill up to $750 per pill for a medication that’s not usually prescribed by itself; it’s typically part of a larger regimen for AIDS and cancer patients. [read post]
24 Sep 2015, 8:43 am by Steve Brachmann
Shortly after acquiring Daraprim, Turing CEO Martin Shkreli raised its price by more than 5,000 percent, from $13.50 per pill up to $750 per pill for a medication that’s not usually prescribed by itself; it’s typically part of a larger regimen for AIDS and cancer patients. [read post]